You're reading the free version. Trader adds the live tape and alerts.
Start tracking
ANTX Sale Disclosure
Readnour Robin Shane · SEC Form 4 · Filed Sep 8, 2026
Sale
Calculated transaction value
$19.56K
Readnour Robin Shane Director
ANTX
Transaction date
Sep 3, 2026
Public filing date
Sep 8, 2026
Filing lag
Filed 5 days later
ANTX daily price context
No linked price history
This asset is not matched to a market-data symbol.
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 3,223 shares @ $6.07
- SEC ownership
- Indirect
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001193125-26-385511
Filing cohort
Transactions in this filing
Showing 4 of 4
Trades
4
Issuers
1
Estimated value
$97.32K
Buys / sales
0 / 4
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| An2 Therapeutics, Inc. ANTX | Sale | Sep 8, 2026 | $28.44K |
| An2 Therapeutics, Inc. ANTX | Sale | Sep 8, 2026 | $31.86K |
| An2 Therapeutics, Inc. ANTX | Sale | Sep 3, 2026 | $17.46K |
| An2 Therapeutics, Inc. ANTX Current | Sale | Sep 3, 2026 | $19.56K |